HRP921353A2 - Biomass for the production of viruses/virus antigenes - Google Patents

Biomass for the production of viruses/virus antigenes

Info

Publication number
HRP921353A2
HRP921353A2 HRP921353A HRP921353A2 HR P921353 A2 HRP921353 A2 HR P921353A2 HR P921353 A HRP921353 A HR P921353A HR P921353 A2 HRP921353 A2 HR P921353A2
Authority
HR
Croatia
Prior art keywords
antigenes
biomass
viruses
virus
production
Prior art date
Application number
Other languages
English (en)
Inventor
Wolfgang Mundt
Wilfried Woehrer
Friedrich Dorner
Johann Eibl
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of HRP921353A2 publication Critical patent/HRP921353A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HRP921353 1990-01-04 1992-11-25 Biomass for the production of viruses/virus antigenes HRP921353A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT18/90A AT393277B (de) 1990-01-04 1990-01-04 Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
YU391A YU391A (sh) 1990-01-04 1991-01-03 Biomasa za proizvodnju virusa/virusantigena

Publications (1)

Publication Number Publication Date
HRP921353A2 true HRP921353A2 (en) 1995-10-31

Family

ID=3479351

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP921353 HRP921353A2 (en) 1990-01-04 1992-11-25 Biomass for the production of viruses/virus antigenes

Country Status (17)

Country Link
US (2) US5391491A (no)
EP (1) EP0509008B1 (no)
JP (1) JP2633392B2 (no)
AT (2) AT393277B (no)
CA (1) CA2073168C (no)
CZ (1) CZ279725B6 (no)
DE (1) DE59103696D1 (no)
DK (1) DK0509008T3 (no)
ES (1) ES2067921T3 (no)
FI (1) FI106241B (no)
HR (1) HRP921353A2 (no)
HU (1) HU212597B (no)
NO (1) NO310472B1 (no)
RU (1) RU2099419C1 (no)
SK (1) SK279200B6 (no)
WO (1) WO1991009937A1 (no)
YU (1) YU391A (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719051A (en) * 1989-12-22 1998-02-17 Immuno Aktiengesellschaft Perfusion system and a method for the large scale production of virus or virus antigen
AT393277B (de) * 1990-01-04 1991-09-25 Immuno Ag Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
JP3158157B2 (ja) 1994-11-10 2001-04-23 バクスター・アクチエンゲゼルシャフト 無蛋白培養における生物製剤の製造法
US5756341A (en) * 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
BR9804283B1 (pt) * 1998-03-18 2010-11-30 processo para a produção de flavivìrus em baixa densidade de células em cultura e processo para a produção de flavivìrus recombinante em baixa densidade de células em cultura.
US7445924B2 (en) * 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US20040023358A1 (en) * 2001-12-21 2004-02-05 Wyeth Avian embryo particulate biomass for the production of virus antigens
PL215169B1 (pl) * 2002-09-05 2013-10-31 Bavarian Nordic As Sposób amplifikacji wirusów, kompozycja zawierajaca pokswirusa uzyskanego tym sposobem oraz jego zastosowanie do otrzymywania szczepionki
US7998488B2 (en) 2008-11-14 2011-08-16 Baxter International Inc. Vaccine formulations and uses thereof
WO2012040474A2 (en) 2010-09-23 2012-03-29 Baxter International Inc. Recombinant viral vectors and methods for inducing an immune response to yellow fever virus
AU2012212463B2 (en) 2011-01-31 2016-07-07 Nanotherapeutics, Inc. Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4059485A (en) * 1976-11-03 1977-11-22 Monsanto Company Adaptation of cell lines to suspension culture
US4195130A (en) * 1978-04-20 1980-03-25 Cornell Research Foundation, Inc. Propagation of feline infectious peritonitis virus in tissue cultures
AT358167B (de) * 1978-12-22 1980-08-25 Immuno Ag Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen
US4335215A (en) * 1980-08-27 1982-06-15 Monsanto Company Method of growing anchorage-dependent cells
AT393277B (de) * 1990-01-04 1991-09-25 Immuno Ag Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
US5114855A (en) * 1990-04-19 1992-05-19 Regents Of The University Of Minnesota Method for aggregating cells with small microspheres

Also Published As

Publication number Publication date
CS9100012A2 (en) 1991-08-13
ES2067921T3 (es) 1995-04-01
FI106241B (fi) 2000-12-29
US5550051A (en) 1996-08-27
EP0509008B1 (de) 1994-11-30
RU2099419C1 (ru) 1997-12-20
HU212597B (en) 1996-08-29
AT393277B (de) 1991-09-25
NO922622D0 (no) 1992-07-02
ATE114713T1 (de) 1994-12-15
ATA1890A (de) 1991-02-15
CA2073168A1 (en) 1991-07-05
HUT64583A (en) 1994-01-28
FI923099A (fi) 1992-07-03
EP0509008A1 (de) 1992-10-21
CA2073168C (en) 1999-04-27
NO310472B1 (no) 2001-07-09
SK279200B6 (sk) 1998-07-08
US5391491A (en) 1995-02-21
YU391A (sh) 1994-04-05
FI923099A0 (fi) 1992-07-03
JPH05503843A (ja) 1993-06-24
JP2633392B2 (ja) 1997-07-23
DK0509008T3 (da) 1995-04-18
NO922622L (no) 1992-07-23
WO1991009937A1 (de) 1991-07-11
DE59103696D1 (de) 1995-01-12
CZ279725B6 (cs) 1995-06-14

Similar Documents

Publication Publication Date Title
IT1154270B (it) Procedimento per la produzione di virus vaccini
HRP921353A2 (en) Biomass for the production of viruses/virus antigenes
FI945441A (fi) Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi
NO912346D0 (no) Fremgangsmaate for fremstilling av aminobenzodiazepiner.
FI883923A (fi) Foerfarande och anordning i samband med spetsdragningen av en pappersbana.
IL98767A0 (en) Process for the preparation of cyclic sulphates
FI102270B1 (fi) Menetelmä dieettereiden valmistamiseksi
HU911984D0 (en) Process for the production of dialkyl piridine-2,3-diacarboxylate and its derivatives
DK516589D0 (da) Fremgangsmaade til fremstilling af polysaccharider ved fermentering ved hjaelp af mikroorganismer
NO179517C (no) Fremgangsmåte for fremstilling av 8-klorkinolonderivater
NO905453L (no) Fremgangsmaate ved fremstilling av klordioksyd.
ZA915396B (en) Process for the preparation of 1-hydroxymethylpyrazoles
HUT44439A (en) Process for inhibiting the reproduction of viruses and virus infections
ZA911768B (en) Process for the preparation of 1-hydroxyalkyl-5-nitroimidazoles
EP0449778A3 (en) Process for the preparation of hydroxyphenylepropionates
NO179101C (no) Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol
EP0464311A3 (en) Anti-virus substance and process for producing the same
FI903304A0 (fi) Foerfarande foer framstaellning av kaffe med laog taethet.
NO178577C (no) Fremgangsmåte til fremstilling av cefalosporin
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
FI943660A0 (fi) Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi
EP0486900A3 (en) Process for the preparation of indoles
ZA918832B (en) Process for the preparation of trioxane
ZA917307B (en) Process for the preparation of aminopyrimidines
NO174960C (no) Fremgangsmåte ved fremstilling av 2-hydroksy-3-halogen-5-nitropyridiner

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ODBC Application rejected